Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Autoantibody status combinations detected for each subject up to visit 2 (n = 57)

From: Heterogeneity of beta-cell function in subjects with multiple islet autoantibodies in the TEDDY family prevention study - TEFA

IAA (n positive subjects = 28)

GADA (n positive subjects = 52)

IA-2A (n positive subjects = 38)

ZnT8W/Q/R (n positive subjects = 40)

Autoantibody count

n (%) subjects with a given autoantibody combination

Autoantibody combination group

+

+

+

+

4

12 (21.1)

A

–

+

+

+

3

10 (17.5)

B

–

+

–

+

2

10 (17.5)

C

+

+

+

–

3

4 (7.0)

D

+

+

–

+

3

3 (5.3)

D

+

+

–

–

2

6 (10.5)

D

+

–

+

+

3

3 (5.3)

D

–

+

+

–

2

7 (12.3)

D

–

–

+

+

2

2 (3.5)

D

  1. The autoantibody combination group in the right-most column was defined based on the three most frequent autoantibody combinations, forming groups A-C (n = 12, 10, 10, respectively), with group D (n = 25) comprised of all remaining autoantibody combinations
Back to article page

Cardiovascular Diabetology – Endocrinology Reports

ISSN: 3059-4057

Contact us